These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8348750)

  • 1. Clustering of neutrophil leucocytes in serum: possible role of C1q-containing immune complexes.
    Sturfelt G; Jonsson H; Hellmer G; Sjöholm AG
    Clin Exp Immunol; 1993 Aug; 93(2):237-41. PubMed ID: 8348750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus.
    Jonsson H; Sturfelt G
    Ann Rheum Dis; 1990 Jan; 49(1):46-50. PubMed ID: 2310227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
    van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
    Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
    Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
    Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus.
    Abramson SB; Given WP; Edelson HS; Weissmann G
    Arthritis Rheum; 1983 May; 26(5):630-6. PubMed ID: 6847725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tests for circulating immune complexes.
    Wener MH
    Methods Mol Biol; 2014; 1134():47-57. PubMed ID: 24497353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
    Daha MR
    Behring Inst Mitt; 1989 Jul; (84):42-6. PubMed ID: 2529843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.
    Hair PS; Enos AI; Krishna NK; Cunnion KM
    Front Immunol; 2018; 9():558. PubMed ID: 29632531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement, interferon and lupus.
    Elkon KB; Santer DM
    Curr Opin Immunol; 2012 Dec; 24(6):665-70. PubMed ID: 22999705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils.
    Starkebaum G; Stevens DL; Henry C; Gavin SE
    J Lab Clin Med; 1981 Aug; 98(2):280-91. PubMed ID: 6972984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.